Business Description

Raphael Pharmaceutical Inc
NAICS : 325411 SIC : 2833
ISIN : US27785B2088
Compare
Compare
Traded in other countries / regions
RAPH.USA
IPO Date
2022-08-23
Description
Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.79
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -18.2
3-Year EPS without NRI Growth Rate -14.5
3-Year FCF Growth Rate -12.9

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 57.21
14-Day RSI 53.8
6-1 Month Momentum % -2.52
12-1 Month Momentum % -53.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.68
Quick Ratio 4.68
Cash Ratio 3.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.1
Shareholder Yield % -6.33
Name Current Vs Industry Vs History
ROE % -5802.63
ROA % -984.38
ROIC % -31261.9
ROC (Joel Greenblatt) % -187571.43
ROCE % -5758.77

Financials

RAPH's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RAPH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Raphael Pharmaceutical Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.17
Beta 0
Volatility % 126.16
14-Day RSI 53.8
14-Day ATR ($) 0.000032
20-Day SMA ($) 1
12-1 Month Momentum % -53.49
52-Week Range ($) 0.6 - 2.3
Shares Outstanding (Mil) 18.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Raphael Pharmaceutical Inc Filings

Filing Date Document Date Form
No Filing Data

Raphael Pharmaceutical Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Raphael Pharmaceutical Inc Frequently Asked Questions

What is Raphael Pharmaceutical Inc(RAPH)'s stock price today?
The current price of RAPH is $1.00. The 52 week high of RAPH is $2.30 and 52 week low is $0.60.
When is next earnings date of Raphael Pharmaceutical Inc(RAPH)?
The next earnings date of Raphael Pharmaceutical Inc(RAPH) is .
Does Raphael Pharmaceutical Inc(RAPH) pay dividends? If so, how much?
Raphael Pharmaceutical Inc(RAPH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1